Banner for leaf pages 2

Lubiprostone (Amitiza)

Also known as Amitiza

Lubiprostone (rINN, marketed under the trade name Amitiza) is a medication used in the management of chronic idiopathic constipation and irritable bowel syndrome. It was approved by the U.S. Food and Drug Administration (FDA) for this purpose on 31 January 2006.

Source: Wikipedia

Estimated Total Cost: $190.37 for an average of 28 days supply

What is it prescribed for?

Patients are most commonly prescribed lubiprostone to treat chronic constipation, constipation, irritable bowel syndrome, and diverticulosis.

What side effects are related?

Patients taking lubiprostone most commonly experience side effects like nausea, headache, and diarrhea.

Ajax-loader Loading...